Uncoupling Protein 2 Deficiency Enhances NLRP3 Inflammasome Activation Following Hyperglycemia-Induced Exacerbation of Cerebral Ischemia and Reperfusion Damage In Vitro and In Vivo

Abstract

Mitochondrial uncoupling protein 2 (UCP2) deficiency exacerbates brain damage following cerebral ischemia/reperfusion (I/R). The Nod-like receptor protein-3 (NLRP3) inflammasome also plays a vital role in cerebral I/R damage. However, the effect of UCP2 on NLRP3 inflammasome-mediated hyperglycemia and I/R damage is not clear. In the present study, UCP2-knockout (UCP2−/−) and wild-type (WT) mice were used to establish a model of middle cerebral artery occlusion (MCAO) and reperfusion under normo- and hyperglycemic conditions. HT22 cells were established as a model of oxygen–glucose deprivation and reoxygenation (OGD/R) with high glucose to mimic hyperglycemia and I/R in vitro. HT22 cells were treated with/without different concentrations of the UCP2-specific inhibitor genipin for different periods of time. The results showed that UCP2 deficiency significantly increased histopathological changes and apoptosis after cerebral I/R damage in hyperglycemic mice. Moreover, UCP2 deficiency enhanced NLRP3 inflammasome activation in neurons when cerebral I/R damage was exacerbated by hyperglycemia. Furthermore, UCP2 deficiency enhanced NLRP3 inflammasome activation and reactive oxygen species (ROS) production in HT22 cells under OGD/R and high-glucose conditions. UCP2 deficiency aggravated hyperglycemia-induced exacerbation of cerebral I/R damage. UCP2 deficiency also enhanced NLRP3 inflammasome activation and ROS production in neurons in vitro and in vivo. These findings suggest that UCP2 deficiency enhances NLRP3 inflammasome activation following hyperglycemia-induced exacerbation of cerebral I/R damage in vitro and in vivo. UCP2 may be a potential therapeutic target for hyperglycemia-induced exacerbation of cerebral I/R damage.

The neuroprotective mechanism of lithium after ischaemic stroke

“…5 ). In UCP2-knockout mice, activation of NLRP3 inflammasome is enhanced by increased ROS production, which exacerbates detrimental effects of ischaemia and reperfusion 58 .…”

Exposure to Maternal Diabetes during Pregnancy Is Associated with Aggravated Short-Term Neonatal and Neurological Outcomes following Perinatal Hypoxic–Ischemic Encephalopathy

“…These hypotheses are supported by fundamental science studies. 44,45 It is also reported that maternal diabetes exposure increases the risk of developing transient tachypnea of the neonate and respiratory distress syndrome at birth due to premature delivery and to the presence of a lower quality and quantity of pulmonary surfactant. 40,46,47 .…”

Exposure to maternal diabetes during pregnancy is associated with worse short-term neonatal and neurological outcomes following perinatal hypoxic-ischemic encephalopathy

“…These hypotheses are supported by fundamental science studies. 42,43 It is also reported that maternal diabetes exposure increases the risk of developing transient tachypnea of the neonate and respiratory distress syndrome at birth due to premature delivery and to the presence of a lower quality and quantity of pulmonary surfactant. 38,44,45 .…”